Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism

Part of paid clinical trials in York, Pennsylvania.

Sponsor
WellSpan Health
Study ID
NCT05050617
Status
Recruiting
Apply to this trial

Conditions

  • Pulmonary Embolism

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Point-of-care echocardiography — DIAGNOSTIC_TEST
    Subjects will undergo point-of-care echocardiography at the time of presentation/enrollment to assess for evidence of right sided heart dilation/strain.

Study Details

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Key Dates

Start date
Sep 9, 2021
Status verified
Jun 2026
Primary completion
Sep 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Acute Pulmonary Embolism
    Subjects in this single cohort will undergo point-of-care echocardiography at the time of presentation and subsequent follow up to assess for short term adverse events or complications.

Primary Outcome Measure

Adverse Events at 5 days [ Time Frame: Within 5 days of presentation/enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Wellspan York HospitalYorkPennsylvania17403
Brent Becker, MD
[email protected]
717 851 4819
Kristen Oliff, BS
[email protected]
717 851 4104

Find similar trials in York, PA

By research site
Wellspan York Hospital· York, PA

Related Studies